Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner

Adams BD, Kasinski AL, Slack FJ (2014) Aberrant regulation and function of microRNAs in cancer. Curr Biol 24:R762-776. https://doi.org/10.1016/j.cub.2014.06.043

CAS  Article  PubMed  PubMed Central  Google Scholar 

An C, Li H, Zhang X, Wang J, Qiang Y, Ye X, Li Q, Guan Q, Zhou Y (2019) Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway. Int J Oncol 54:1195–1208. https://doi.org/10.3892/ijo.2019.4717

CAS  Article  PubMed  PubMed Central  Google Scholar 

Bhandari A, Zheng C, Sindan N, Sindan N, Quan R, Xia E, Thapa Y, Tamang D, Wang O, Ye X, Huang D (2019) COPB2 is up-regulated in breast cancer and plays a vital role in the metastasis via N-cadherin and Vimentin. J Cell Mol Med 23:5235–5245. https://doi.org/10.1111/jcmm.14398

CAS  Article  PubMed  PubMed Central  Google Scholar 

Blair LP, Cao J, Zou MR, Sayegh J, Yan Q (2011) Epigenetic Regulation by Lysine Demethylase 5 (KDM5) enzymes in cancer. Cancers (basel) 3:1383–1404. https://doi.org/10.3390/cancers3011383

CAS  Article  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Chen H, Zhou L, Wu X, Li R, Wen J, Sha J, Wen X (2016) The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (landmark Ed) 21:1084–1091. https://doi.org/10.2741/4443

CAS  Article  Google Scholar 

Chen T, Yang Z, Liu C, Wang L, Yang J, Chen L, Li W (2019) Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p. Cell Prolif 52:e12548. https://doi.org/10.1111/cpr.12548

CAS  Article  PubMed  Google Scholar 

Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, Li C, Sun L, Qin J, Xu T, He B, Pan Y, Sun H, Wang S (2020) METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer 19:106. https://doi.org/10.1186/s12943-020-01220-7

CAS  Article  PubMed  PubMed Central  Google Scholar 

Chou NH, Lo YH, Wang KC, Kang CH, Tsai CY, Tsai KW (2018) MiR-193a-5p and -3p play a distinct role in gastric cancer: miR-193a-3p suppresses gastric cancer cell growth by targeting ETS1 and CCND1. Anticancer Res 38:3309–3318. https://doi.org/10.21873/anticanres.12596

CAS  Article  PubMed  Google Scholar 

Cui J, Quan M, Xie D, Gao Y, Guha S, Fallon MB, Chen J, Xie K (2020) A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism. Oncogene 39:1140–1151. https://doi.org/10.1038/s41388-019-1051-8

CAS  Article  PubMed  Google Scholar 

Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77:38–52. https://doi.org/10.1016/j.eururo.2019.08.005

Article  PubMed  Google Scholar 

Dai B, Huang H, Guan F, Zhu G, Xiao Z, Mao B, Su H, Hu Z (2018) Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1. Biomed Pharmacother 99:72–80. https://doi.org/10.1016/j.biopha.2018.01.020

CAS  Article  PubMed  Google Scholar 

Dittmer J (2015) The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol 35:20–38. https://doi.org/10.1016/j.semcancer.2015.09.010

CAS  Article  PubMed  Google Scholar 

Du C, Lv C, Feng Y, Yu S (2020) Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. J Exp Clin Cancer Res 39:223. https://doi.org/10.1186/s13046-020-01735-3

CAS  Article  PubMed  PubMed Central  Google Scholar 

Foroozan M, Roudi R, Abolhasani M, Gheytanchi E, Mehrazma M (2017) Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinoma. Pathol Res Pract 213:612–618. https://doi.org/10.1016/j.prp.2017.04.027

CAS  Article  PubMed  Google Scholar 

Ghafouri-Fard S, Shoorei H, Taheri M (2020) Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer. Gene 759:144995. https://doi.org/10.1016/j.gene.2020.144995

CAS  Article  PubMed  Google Scholar 

Harris TA, Yamakuchi M, Kondo M, Oettgen P, Lowenstein CJ (2010) Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells. Arterioscler Thromb Vasc Biol 30:1990–1997. https://doi.org/10.1161/ATVBAHA.110.211706

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hong Z, Wu G, Xiang ZD, Xu CD, Huang SS, Li C, Shi L, Wu DL (2019) KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN. Biomed Pharmacother 114:108793. https://doi.org/10.1016/j.biopha.2019.108793

CAS  Article  PubMed  Google Scholar 

Huang Y, Sun H, Ma X, Zeng Y, Pan Y, Yu D, Liu Z, Xiang Y (2020) HLA-F-AS1/miR-330-3p/PFN1 axis promotes colorectal cancer progression. Life Sci 254:117180. https://doi.org/10.1016/j.lfs.2019.117180

CAS  Article  PubMed  Google Scholar 

Itoh T, Takeda S, Akao Y (2010) MicroRNA-208 modulates BMP-2-stimulated mouse preosteoblast differentiation by directly targeting V-ets erythroblastosis virus E26 oncogene homolog 1. J Biol Chem 285:27745–27752. https://doi.org/10.1074/jbc.M110.105080

CAS  Article  PubMed  PubMed Central  Google Scholar 

Janevska S, Guldener U, Sulyok M, Tudzynski B, Studt L (2018) Set1 and Kdm5 are antagonists for H3K4 methylation and regulators of the major conidiation-specific transcription factor gene ABA1 in Fusarium fujikuroi. Environ Microbiol 20:3343–3362. https://doi.org/10.1111/1462-2920.14339

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jin Z, Jia B, Tan L, Liu Y (2019) miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1. Oncol Lett 18:314–320. https://doi.org/10.3892/ol.2019.10280

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kang AD, Cosenza SC, Bonagura M, Manair M, Reddy MV, Reddy EP (2013) ON01210.Na (Ex-RAD(R)) mitigates radiation damage through activation of the AKT pathway. PLoS ONE. https://doi.org/10.1371/journal.pone.0058355

Article  PubMed  PubMed Central  Google Scholar 

Kar A, Gutierrez-Hartmann A (2013) Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit Rev Biochem Mol Biol 48:522–543. https://doi.org/10.3109/10409238.2013.838202

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kato M, Dang V, Wang M, Park JT, Deshpande S, Kadam S, Mardiros A, Zhan Y, Oettgen P, Putta S, Yuan H, Lanting L, Natarajan R (2013) TGF-beta induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal. https://doi.org/10.1126/scisignal.2003389

Article  PubMed  PubMed Central  Google Scholar 

Kern HB, Niemeyer BF, Parrish JK, Kerr CA, Yaghi NK, Prescott JD, Gutierrez-Hartmann A, Jedlicka P (2012) Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors. DNA Cell Biol 31:1403–1411. https://doi.org/10.1089/dna.2011.1469

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kfir-Elirachman K, Ortenberg R, Vizel B, Besser MJ, Barshack I, Schachter J, Nemlich Y, Markel G (2018) Regulation of CEACAM1 protein expression by the transcription factor ETS-1 in BRAF-mutant human metastatic melanoma cells. Neoplasia 20:401–409. https://doi.org/10.1016/j.neo.2018.01.012

CAS  Article  PubMed  PubMed Central  Google Scholar 

Khan MI, Hamid A, Rath S, Ateeq B, Khan Q, Siddiqui IA, Adhami VM, Choudhry H, Zamzami MA, Mukhtar H (2019) AKT inhibition modulates H3K4 demethylase levels in PTEN-null prostate cancer. Mol Cancer Ther 18:356–363. https://doi.org/10.1158/1535-7163.MCT-18-0141

CAS  Article  PubMed  Google Scholar 

Kirtana R, Manna S, Patra SK (2020) Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease. Exp Cell Res 396:112314. https://doi.org/10.1016/j.yexcr.2020.112314

CAS  Article  PubMed  Google Scholar 

Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW (2018) ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. J Clin Invest 128:2979–2995. https://doi.org/10.1172/JCI96769

Article  PubMed  PubMed Central  Google Scholar 

Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693–705. https://doi.org/10.1016/j.cell.2007.02.005

CAS  Article  PubMed  Google Scholar 

Lee CG, Kwon HK, Sahoo A, Hwang W, So JS, Hwang JS, Chae CS, Kim GC, Kim JE, So HS, Hwang ES, Grenningloh R, Ho IC, Im SH (2012) Interaction of Ets-1 with HDAC1 represses IL-10 expression in Th1 cells. J Immunol 188:2244–2253. https://doi.org/10.4049/jimmunol.1101614

CAS  Article  PubMed  Google Scholar 

Li N, Dhar SS, Chen TY, Kan PY, Wei Y, Kim JH, Chan CH, Lin HK, Hung MC, Lee MG (2016) JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis. Cancer Res 76:831–843. https://doi.org/10.1158/0008-5472.CAN-15-0906

CAS  Article  PubMed  PubMed Central  Google Scholar 

Li G, Kanagasabai T, Lu W, Zou MR, Zhang SM, Celada SI, Izban MG, Liu Q, Lu T, Ballard BR, Zhou X, Adunyah SE, Matusik RJ, Yan Q, Chen Z (2020a) KDM5B is essential for the hyperactivation of PI3K/AKT signaling in prostate tumorigenesis. Cancer Res 80:4633–4643. https://doi.org/10.1158/0008-5472.CAN-20-0505

留言 (0)

沒有登入
gif